Key Highlights

  • Taboola.com (NASDAQ:TBLA) rose 2.05% on October 15, with a market value of USD 942.84 million, with a market value of USD 942.84 million, with a market value of USD 942.84 million, with a market value of USD 942.84 million.
  • Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19% on October 15, with a market value of USD 1.6 billion, with a market value of USD 1.6 billion, with a market value of USD 1.6 billion.
  • Cronos Group (NASDAQ:CRON) rose 1.74% on October 15, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion, with a market value of USD 1.18 billion.
  • ECARX Holdings (NASDAQ:ECX) fell 2.41% on October 15, with a market value of USD 323.78 million, with a market value of USD 323.78 million, with a market value of USD 323.78 million, with a market value of USD 323.78 million.

Taboola.com (NASDAQ:TBLA): Valuation in Focus

Taboola.com (NASDAQ:TBLA) rose 2.05% to a listed USD 3.49 on 497,320 shares, with a market capitalization of USD 942.84 million, a P/E of 8.62. Taboola.com, classified in technology services, rose 2.05% to USD 3.49 on October 15 on 497,320 shares, with a market value of USD 942.84 million. Taboola reported second-quarter revenue of USD 476.8 million, up 2.4%, ex-TAC gross profit of USD 192.4 million, up 11.8%, adjusted EBITDA of USD 55.5 million, up 22.8% with a 28.8% margin, and net income of USD 4.3 million against a loss a year earlier. The shares fell about 30% to USD 3.71 on the August 5 report despite the raise, as revenue and gross profit missed guidance and Google policy changes and a publisher network cleanup weighed on growth. At USD 3.49 the stock trades at 8.62 times trailing earnings and its USD 942.8 million market value is about 4 times the midpoint of adjusted EBITDA guidance, before net debt, with USD 133.1 million of cash at quarter-end. Trailing diluted EPS is USD 0.40, a P/E of 8.62, with EPS growth of 1,003.00% year on year. The day's change implies a prior close near USD 3.4199, a move of about USD 0.0701 a share. Small-cap equities with limited liquidity can move sharply on financing, guidance and macro headlines, and trailing earnings can overstate or understate current profitability. By market value it ranks 3 of 5 in this group. What to watch next: ex-TAC gross profit growth, free cash flow conversion and Google policy effects.

Melco Resorts and Entertainment (NASDAQ:MLCO): Valuation in Focus

Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19% to a listed USD 4.25 on 769,200 shares, with a market capitalization of USD 1.6 billion, a P/E of 7.11. Melco Resorts and Entertainment, classified in consumer services, rose 1.19% to USD 4.25 on October 15 on 769,200 shares, with a market value of USD 1.6 billion. Melco Resorts reported second-quarter net income of USD 22.7 million, or USD 0.06 per ADS, and operating income of USD 127.8 million, while adjusted property EBITDA fell to USD 303.8 million from USD 377.7 million a year earlier. At USD 4.25 the ADS trade at 7.11 times trailing earnings, with trailing EPS growth of 336%, on a market value of USD 1.6 billion. The decline in property EBITDA, about 20%, shows that trailing earnings overstate current run-rate profitability, so the low multiple reflects the Macau and Cyprus operating outlook. Trailing diluted EPS is USD 0.60, a P/E of 7.11, with EPS growth of 336.11% year on year. The day's change implies a prior close near USD 4.2000, a move of about USD 0.0500 a share. By market value it ranks 1 of 5 in this group. What to watch next: Macau gross gaming revenue, margins and debt reduction.

Cronos Group (NASDAQ:CRON): Valuation in Focus

Cronos Group (NASDAQ:CRON) rose 1.74% to a listed USD 3.22 on 323,080 shares, with a market capitalization of USD 1.18 billion, a P/E of 17.97. Cronos Group, classified in health technology, rose 1.74% to USD 3.22 on October 15 on 323,080 shares, with a market value of USD 1.18 billion. Cronos Group rose 1.74% to USD 3.22, with trailing EPS of USD 0.18, growth of 259.75% and a market value of USD 1.18 billion. The trailing earnings include non-operating items, so the 17.97 multiple should be cross-checked against operating results. Company-specific second-quarter results were not verified in this review, so the valuation case rests on the earnings trend and balance sheet. Trailing diluted EPS is USD 0.18, a P/E of 17.97, with EPS growth of 259.75% year on year. The day's change implies a prior close near USD 3.1649, a move of about USD 0.0551 a share. By market value it ranks 2 of 5 in this group. What to watch next: operating profitability, cash balance and regulatory developments.

ECARX Holdings (NASDAQ:ECX): Valuation in Focus

ECARX Holdings (NASDAQ:ECX) fell 2.41% to a listed USD 0.9076 on 592,800 shares, with a market capitalization of USD 323.78 million. ECARX Holdings, classified in technology services, fell 2.41% to USD 0.9076 on October 15 on 592,800 shares, with a market value of USD 323.78 million. ECARX, a supplier of automotive computing platforms and software, fell 2.41% to USD 0.9076, while its trailing loss per share of USD 0.05 narrowed 85.14% year on year. At a market value of USD 323.8 million the shares trade below USD 1.00, which exposes the company to Nasdaq minimum bid price scrutiny if the level persists. The narrowing loss indicates operating leverage as vehicle programs scale, but the lack of positive earnings keeps the valuation dependent on order intake from automakers. Trailing diluted EPS is negative USD 0.05, with EPS growth of 85.14% year on year. The day's change implies a prior close near USD 0.9300, a move of about USD 0.0224 a share. By market value it ranks 5 of 5 in this group. What to watch next: program launches, gross margin and the Nasdaq minimum bid price standard.

Cerus (NASDAQ:CERS): Valuation in Focus

Cerus (NASDAQ:CERS) rose 0.67% to a listed USD 2.26 on 607,600 shares, with a market capitalization of USD 454.44 million. Cerus, classified in health technology, rose 0.67% to USD 2.26 on October 15 on 607,600 shares, with a market value of USD 454.44 million. Cerus reported second-quarter product revenue of USD 57.4 million, up 10%, and total revenue of USD 63.3 million, up 5%, with growth across all product categories. A recent debt refinancing and a loss per share of USD 0.03 that narrowed 65.57% show progress toward profitability. At USD 2.26 the shares trade at about 2.0 times the midpoint of product revenue guidance on a market value of USD 454.4 million. Trailing diluted EPS is negative USD 0.03, with EPS growth of 65.57% year on year. The day's change implies a prior close near USD 2.2450, a move of about USD 0.0150 a share. By market value it ranks 4 of 5 in this group. What to watch next: FDA decision timing, product growth and profitability.

Where Things Stand

The highest EPS growth readings come from recoveries off weak prior-year bases, so they overstate sustainable growth. Taboola.com (NASDAQ:TBLA) rose 2.05%. Melco Resorts and Entertainment (NASDAQ:MLCO) rose 1.19%. Cronos Group (NASDAQ:CRON) rose 1.74%. ECARX Holdings (NASDAQ:ECX) fell 2.41%. Cerus (NASDAQ:CERS) rose 0.67%. Moves on stocks this small often reverse, so the balance of evidence favors waiting for filings and the next session. Direction remains unknown, and each name carries its own risks. Check each company's filings for the drivers behind the move, verify the latest filings before acting, and treat the figures as a snapshot.